| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | UROPLASTY INC | 668,287 | 1,791,000 | 0.18% | ||
| 52 | SMITH & NEPHEW PLC | 22,963 | 2,050,000 | 0.20% | ||
| 53 | GENVEC INC | 820,000 | 2,107,000 | 0.21% | ||
| 54 | ACHILLION PHARMACEUTICALS IN | 280,000 | 2,120,000 | 0.21% | ||
| 55 | KARYOPHARM THERAPEUTICS INC COM | 45,643 | 2,125,000 | 0.21% | ||
| 56 | COVIDIEN PLC | 25,000 | 2,255,000 | 0.22% | ||
| 57 | FIVE PRIME THERAPEUTICS INC | 150,000 | 2,333,000 | 0.23% | ||
| 58 | ACASTI PHARMA INC | 2,566,785 | 2,437,000 | 0.24% | ||
| 59 | QUOTIENT LTD | 300,000 | 2,499,000 | 0.25% | ||
| 60 | MGC DIAGNOSTICS CORP | 316,459 | 2,652,000 | 0.26% | ||
| 61 | VERTEX PHARMACEUTICALS INC | 30,000 | 2,840,000 | 0.28% | Put | |
| 62 | ZELTIQ AESTHETICS INC | 201,628 | 3,065,000 | 0.30% | ||
| 63 | TESARO INCORPORATED | 100,000 | 3,111,000 | 0.31% | Put | |
| 64 | AEGERION PHARMACEUTICALS INC | 100,000 | 3,209,000 | 0.31% | Call | |
| 65 | CHIMERIX INC | 148,000 | 3,241,000 | 0.32% | ||
| 66 | APPLIED GENETIC TECHNOL CORP | 146,978 | 3,395,000 | 0.33% | ||
| 67 | ARNO THERAPEUTIC INC | 2,034,721 | 3,621,000 | 0.36% | ||
| 68 | Walgreens | 50,000 | 3,707,000 | 0.36% | Call | |
| 69 | CATALYST PHARMACEUTICALS INC | 1,500,000 | 3,795,000 | 0.37% | ||
| 70 | AERIE PHARMACEUTICALS INC COM | 1,121,951 | 4,196,000 | 0.41% | ||
| 71 | TREVENA INC | 770,000 | 4,351,000 | 0.43% | ||
| 72 | CENTENE CORP DEL | 60,000 | 4,537,000 | 0.45% | ||
| 73 | DERMA SCIENCES ORD | 406,437 | 4,698,000 | 0.46% | ||
| 74 | INTERCEPT PHARMACEUTICALS INCORPORATED | 20,000 | 4,733,000 | 0.46% | Put | |
| 75 | SPECTRANETICS CORP | 243,354 | 5,568,000 | 0.55% | ||
| 76 | REGADO BIOSCIENCES INC | 860,000 | 5,839,000 | 0.57% | ||
| 77 | Arrowhead Pharma Inc | 422,406 | 6,045,000 | 0.59% | ||
| 78 | TRANSENTERIX INC | 1,300,000 | 6,552,000 | 0.64% | ||
| 79 | Medtronic Inc | 130,000 | 8,289,000 | 0.81% | ||
| 80 | BIODELIVERY SCIENCES INTL IN | 700,000 | 8,449,000 | 0.83% | ||
| 81 | Allergan plc | 50,000 | 8,461,000 | 0.83% | ||
| 82 | Receptos Inc | 205,000 | 8,733,000 | 0.86% | ||
| 83 | VERSARTIS INC | 315,796 | 8,855,000 | 0.87% | ||
| 84 | INTERMUNE INC | 210,000 | 9,272,000 | 0.91% | ||
| 85 | Anacor Pharmaceuticals Inc | 528,776 | 9,375,000 | 0.92% | ||
| 86 | MACROGENICS INC | 431,803 | 9,383,000 | 0.92% | ||
| 87 | ACCELERON PHARMA INC | 300,000 | 10,191,000 | 1.00% | ||
| 88 | AETNA INC NEW | 131,308 | 10,646,000 | 1.04% | ||
| 89 | PROTHENA CORP PLC | 483,162 | 10,895,000 | 1.07% | ||
| 90 | HCA HOLDINGS INC | 197,806 | 11,152,000 | 1.09% | ||
| 91 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 800,000 | 12,000,000 | 1.18% | ||
| 92 | SANGAMO THERAPEUTICS INCORPORATED | 800,000 | 12,216,000 | 1.20% | ||
| 93 | RELYPSA INC | 596,605 | 14,509,000 | 1.42% | ||
| 94 | National Australia Bank ADR | 282,500 | 14,566,000 | 1.43% | ||
| 95 | ACADIA PHARMACEUTICALS INC COM | 653,000 | 14,751,000 | 1.45% | ||
| 96 | RETROPHIN INC | 1,274,292 | 14,960,000 | 1.47% | ||
| 97 | EXACT SCIENCES CORP | 901,250 | 15,348,000 | 1.51% | ||
| 98 | OPHTHOTECH CORP | 371,469 | 15,717,000 | 1.54% | ||
| 99 | PTC THERAPEUTICS INC | 671,736 | 17,559,000 | 1.72% | ||
| 100 | NEPTUNE TECHNOLOGIES BIORESO | 6,700,444 | 18,493,000 | 1.81% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-14-001053, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
